Secondly, the study population included patients in different phases of the disease evolution (cirrhosis, early-stage HCC, and metastatic HCC) and the values of AFP, ESR, and CRP may greatly differ at these different stages of the disease. The gene discussed is AFP; the disease is hepatocellular carcinoma.